Posts by Sandra Ansanay-Alex
Le Temps – Medtechs still trapped in European reform on medical devices
Medical technology companies are still grappling with the new rules on healthcare devices and diagnostics, two years after they came into force. These changes are costly and time-consuming. ⚠️ This article was written by Etienne Meyer-Vacherand and was originally published in French in Le Temps. Two years on, the chaos caused by the…
Read MoreOncolifestyle, Debiopharm’s website to empower people living with cancer
The Swiss-based biopharmaceutical company launches a new online portal to support people with cancer, with an initial focus on prostate cancer. JULY 6, 2023 As recent studies show the importance of lifestyle habits in the management of cancer, this website has been designed to share relevant recommendations for patients, with a first focus…
Read MoreProf. Antoine Geissbuhler appointed Dean of UNIGE Faculty of Medicine
BioAlps President, Prof. Antoine Geissbuhler, takes a new position. He is now at the helm of UNIGE Faculty of Medicine. Antoine Geissbuhler is a doctor specializing in medical informatics. A full professor since 2006, he is also director of the HUG Innovation Center and head physician of the eHealth and Telemedicine Service, recognized as…
Read MoreCHUV launches a new cellular immunotherapy to treat acute myeloid leukemia
This subtype of cancer, which is particularly aggressive in children and frequent in adults, responds poorly to current standard treatments. Thanks to a private donation of CHF 2.8 million coordinated by the ISREC Foundation, the CHUV will pursue promising research, with the aim of launching a clinical trial at the end of 2024. The…
Read MoreGender medicine: Switzerland invests CHF11 million
The Swiss government is investing CHF47 million in four national research programmes: gender medicine, biodiversity, new construction techniques and crop cultivation. Some CHF11 million will be spent on enhancing knowledge of gender aspects in medical research and healthcare. The results will be translated into guidelines for doctors, nursing staff and the pharmaceutical industry.…
Read Moredsm-firmenich invests € 275 Million into Adare Biome
Adare Biome, a unit of Adare Pharma Solutions (CDMO), is a historic player in the development and manufacturing of postbiotic ingredients. The agreement will help the dutch-swiss group dsm-firmenich reinforce its “Health from the Gut” strategy. Tom Sellig, CEO of Adare Pharma Solutions, commented: “As part of our efforts to take Adare Biome…
Read MoreFONGIT Innovation Initiation Program for Life Sciences – and Deep Tech Projects
In 2016 FONGIT, in Geneva, and EPFL Innovation Park launched the Geneus program – the first innovation initiation program – transforming life sciences research into startup projects. After 7 successful years in which 150 innovators were supported, FONGIT has upgraded this program and extended the approach to all areas of deep tech, becoming the FONGIT…
Read MoreAC Immune Receives FDA Fast Track Designation for its Alzheimer’s Vaccine candidate
Lausanne-based biopharmaceutical company AC Immune SA, announced that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its wholly-owned anti-amyloid beta (Abeta) active immunotherapy (vaccine)-candidate, ACI-24.060, for treatment of Alzheimer’s disease. This follows FDA clearance of the Investigational New Drug (IND) application enabling expansion to the USA of…
Read MoreDéfi Source 2023 rewards 6 innovative projects focusing on people and society
Over 150 innovation and healthcare players attended the presentations of the 12 finalist projects during the finale of the second edition of Défi Source, at the Institut et Haute École de la Santé La Source in Lausanne. 8 prizes were awarded to the most innovative projects. The winning projects The Prix du Jury…
Read MoreDewi, DNAQuraCy, naialabs and MagFlow awarded grants from FIT
The FIT, (Fondation pour l’Innovation Technologique) in canton of Vaud awarded 4 promising Swiss Health Valley projects. DNAQuraCy spun out of UNIL/CHUV and works on the next generation DNA sequencing tools. The three other projects are spin-offs from EPFL: Dewi anticipates anxiety attacks through neuroscience, naialabs allows at-home blood testing and MagFlow is miniaturizing microcatheters.…
Read More